You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 6, 2025

Drug Price Trends for NDC 81565-0202


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 81565-0202

Drug NameNDCPrice/Unit ($)UnitDate
DEXAMETHASONE 4 MG/ML VIAL 81565-0202-02 0.78606 ML 2025-03-19
DEXAMETHASONE 4 MG/ML VIAL 81565-0202-02 0.77430 ML 2025-02-19
DEXAMETHASONE 4 MG/ML VIAL 81565-0202-02 0.76330 ML 2025-01-22
DEXAMETHASONE 4 MG/ML VIAL 81565-0202-02 0.76549 ML 2024-12-18
DEXAMETHASONE 4 MG/ML VIAL 81565-0202-02 0.75870 ML 2024-11-20
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 81565-0202

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for NDC 81565-0202: Dexamethasone Sodium Phosphate

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing crucial roles in shaping the healthcare landscape. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug identified by National Drug Code (NDC) 81565-0202, which corresponds to Dexamethasone Sodium Phosphate.

Understanding NDC 81565-0202: Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate is a potent corticosteroid used to treat various conditions, including arthritis, blood disorders, allergic reactions, skin diseases, eye problems, and breathing difficulties[10]. As a widely prescribed medication, understanding its market position and price trends is crucial for healthcare providers, patients, and industry stakeholders.

The Significance of National Drug Codes

The National Drug Code (NDC) is a unique, three-segment number assigned by the FDA to identify human drugs in the United States[7]. For NDC 81565-0202:

  • 81565: Represents the labeler code
  • 02: Identifies the product code
  • 02: Indicates the package code

This system allows for precise tracking and analysis of specific drug formulations and package sizes, which is essential for market analysis and price projections.

Current Market Landscape for Dexamethasone Sodium Phosphate

To understand the market position of Dexamethasone Sodium Phosphate, we need to examine the broader pharmaceutical industry trends and how they impact this specific drug.

U.S. Pharmaceutical Market Overview

The U.S. pharmaceutical market is experiencing significant growth:

The US pharmaceutical market is projected to grow from US$ 846.72 billion in 2022 to US$ 1.28 trillion by 2030, representing a Compound Annual Growth Rate (CAGR) of 5.36% from 2022 to 2030[3].

This growth is driven by factors such as:

  • Rising workplace-associated disorders
  • Increased pharmaceutical production capacity
  • Greater approvals of generic drugs
  • Escalating R&D investments

Dexamethasone Sodium Phosphate's Market Position

While specific market share data for Dexamethasone Sodium Phosphate (NDC 81565-0202) is not provided in the search results, we can infer its importance based on its wide range of applications. As a versatile corticosteroid, it likely maintains a significant presence in the pharmaceutical market, particularly in treating inflammatory and autoimmune conditions.

Price Analysis for NDC 81565-0202

To project future prices for Dexamethasone Sodium Phosphate, we must consider current pricing trends and factors influencing drug prices in the U.S. market.

General Pricing Trends in the U.S. Pharmaceutical Market

The U.S. pharmaceutical market is known for its higher drug prices compared to other countries:

  • In 2022, the average price per unit in the U.S. was 5.5 times higher than in OECD countries (excluding the U.S.)
  • U.S. drug prices were 7.7 times higher than in the rest of the world[2]

Seasonal Price Increase Patterns

Drug price increases in the U.S. often follow a predictable pattern:

  • The largest number of price increases occur in January and July each year
  • In 2022, over 3,000 drugs experienced a price increase in January
  • The average increase was nearly $150 per drug, representing a 10% increase[2]

Significant Price Changes

Some drugs experience substantial price hikes:

  • 15-18% of price increases in January and July 2022 were considered significant
  • Significant changes were defined as:
    • A price change greater than $20 per package with at least a 10% increase
    • Any change greater than $500 per package[2]

Factors Influencing Price Projections for Dexamethasone Sodium Phosphate

Several factors could impact the future pricing of Dexamethasone Sodium Phosphate:

1. Patent Status and Generic Competition

The patent status of a drug significantly influences its pricing. As Dexamethasone is an older drug, it's likely off-patent, which could lead to increased generic competition and potentially lower prices.

2. Manufacturing Costs and Supply Chain Issues

Any changes in production costs or supply chain disruptions could impact the drug's price. The COVID-19 pandemic has highlighted the vulnerability of pharmaceutical supply chains, which could affect pricing.

3. Regulatory Environment

Changes in drug pricing regulations could significantly impact the cost of Dexamethasone Sodium Phosphate. Recent legislative efforts to control drug prices may influence future pricing strategies.

4. Market Demand

The wide range of conditions treated by Dexamethasone Sodium Phosphate suggests a consistent demand, which could stabilize prices. However, emerging alternative treatments could impact this demand.

5. Healthcare Policy Changes

Any shifts in healthcare policies, such as changes to Medicare drug pricing negotiations, could affect the pricing of drugs like Dexamethasone Sodium Phosphate.

Price Projections for Dexamethasone Sodium Phosphate

While specific price projections for NDC 81565-0202 are not available in the search results, we can make some informed estimates based on general market trends:

Short-Term Projections (1-2 years)

According to Vizient's summer Pharmacy Market Outlook for 2024, the overall drug price inflation rate for 2025 is projected to be 3.81%[5]. Applying this to Dexamethasone Sodium Phosphate, we might expect a modest price increase in line with this projection.

Long-Term Projections (3-5 years)

Long-term price projections are more challenging due to the many variables involved. However, considering the overall growth of the U.S. pharmaceutical market (projected CAGR of 5.36% from 2022 to 2030)[3], we might anticipate continued price increases for Dexamethasone Sodium Phosphate, albeit potentially moderated by factors such as generic competition and regulatory pressures.

Market Strategies for Stakeholders

Given the market analysis and price projections for Dexamethasone Sodium Phosphate, various stakeholders should consider the following strategies:

For Pharmaceutical Companies

  1. Invest in efficient manufacturing processes to maintain competitive pricing
  2. Explore value-based pricing models to justify costs based on patient outcomes
  3. Develop innovative formulations or delivery methods to differentiate from competitors

For Healthcare Providers

  1. Monitor price trends to make informed decisions about drug procurement
  2. Consider alternative treatments when appropriate to manage costs
  3. Engage in negotiations with suppliers to secure favorable pricing

For Patients and Advocacy Groups

  1. Stay informed about pricing trends and available generic alternatives
  2. Advocate for pricing transparency and fair drug pricing policies
  3. Explore patient assistance programs offered by pharmaceutical companies

The Role of Technology in Drug Price Projections

Advancements in technology are playing an increasingly important role in drug price projections and market analysis:

Artificial Intelligence in Drug Discovery

The increasing adoption of AI-based tools for drug discovery is a significant trend in the pharmaceutical industry[3]. This could potentially lead to more efficient drug development processes, which may impact pricing strategies in the long term.

Data Analytics for Market Insights

Companies like Komodo Health are leveraging advanced data analytics to provide more accurate drug projections:

Komodo Drug Projections' advanced model is based on three pillars that ensure you obtain the most accurate projections for devising key metrics such as revenue forecast, market share, marketing ROI, and salesforce size[6].

These technological advancements allow for more precise market analysis and price projections, benefiting all stakeholders in the pharmaceutical industry.

Key Takeaways

  • The U.S. pharmaceutical market is growing rapidly, projected to reach $1.28 trillion by 2030
  • Drug prices in the U.S. are significantly higher than in other countries, with regular increases occurring in January and July
  • Dexamethasone Sodium Phosphate (NDC 81565-0202) is a widely used corticosteroid with various applications
  • Short-term price projections suggest a potential 3.81% increase in line with overall drug price inflation
  • Long-term projections are more uncertain but may follow the industry's growth trend of 5.36% CAGR
  • Factors influencing price include patent status, manufacturing costs, regulatory environment, market demand, and healthcare policies
  • Stakeholders should adopt strategies to navigate the evolving pricing landscape, including investing in efficient manufacturing, exploring value-based pricing, and staying informed about market trends
  • Technological advancements in AI and data analytics are playing an increasingly important role in drug price projections and market analysis

FAQs

  1. Q: How often do drug prices typically increase in the U.S.? A: Drug prices in the U.S. typically see the largest number of increases in January and July each year.

  2. Q: What is the significance of the National Drug Code (NDC)? A: The NDC is a unique identifier for human drugs in the U.S., allowing for precise tracking and analysis of specific drug formulations and package sizes.

  3. Q: How does the patent status of a drug affect its pricing? A: When a drug's patent expires, it opens the market to generic competition, which can lead to lower prices for that medication.

  4. Q: What role does artificial intelligence play in drug pricing? A: AI is increasingly used in drug discovery and development, potentially leading to more efficient processes that could impact future pricing strategies.

  5. Q: How can patients manage the impact of rising drug prices? A: Patients can stay informed about pricing trends, explore generic alternatives when available, and look into patient assistance programs offered by pharmaceutical companies.

Sources cited: [2] https://dfr.oregon.gov/drugtransparency/Documents/Prescription-Drug-Price-Transparency-Annual-Report-2022.pdf [3] https://www.globenewswire.com/news-release/2024/03/27/2853180/28124/en/US-Pharmaceutical-Market-Review-2020-2023-and-Forecast-2024-2030-A-1-28-Trillion-Opportunity-Driven-by-the-Rising-Adoption-of-AI-based-Tools-for-Drug-Discovery.html [5] https://www.drugpatentwatch.com/p/drug-price/ndc/00115-1320 [6] https://www.komodohealth.com/komodo-drug-projections/ [7] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information [10] https://ndclist.com/ndc/81565-202/package/81565-202-02

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.